Cargando…
Oral nano-delivery of anticancer ginsenoside 25-OCH(3)-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
The Mouse Double Minute 2 (MDM2) oncogene plays a critical role in cancer development and progression through p53-dependent and p53-independent mechanisms. Both natural and synthetic MDM2 inhibitors have been shown anticancer activity against several human cancers. We have recently identified a nove...
Autores principales: | Voruganti, Sukesh, Qin, Jiang-Jiang, Sarkar, Sushanta, Nag, Subhasree, Walbi, Ismail A., Wang, Shu, Zhao, Yuqing, Wang, Wei, Zhang, Ruiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673272/ https://www.ncbi.nlm.nih.gov/pubmed/26041888 |
Ejemplares similares
-
Natural Product Ginsenoside 25-OCH(3)-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2
por: Wang, Wei, et al.
Publicado: (2012) -
Genotoxicity and subchronic toxicological study of a novel ginsenoside derivative 25-OCH(3)-PPD in beagle dogs
por: Li, Wei, et al.
Publicado: (2019) -
Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
por: Qin, Jiang-Jiang, et al.
Publicado: (2016) -
Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
por: Qin, Jiang-Jiang, et al.
Publicado: (2016) -
Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action
por: Nag, Subhasree Ashok, et al.
Publicado: (2012)